Search Results for: DNA VACCINE TECHNOLOGY A Vaccine
Articles
GENE & CELL THERAPY - Its Growing Potential to Disrupt Drug Research & Healthcare Delivery October 2, 2017
Jeff Galvin believes as the pace of gene and cell therapies accelerates over this next decade, potential cures for chronic diseases, cancer cures, and autosomal defect cures will result, and the efficacy of new therapeutics may move as much as $500 billion from traditional pharmaceuticals to gene technologies.
SPECIAL FEATURE - Platform Technologies: Not Just for Big Pharma October 3, 2016
Contributor Cindy H. Dubin recently spoke with several companies that are debunking the theory that access to the latest technological platforms to aid efficient drug discovery and development is limited to Big Pharma, which can more easily justify the costs of creating and operating innovative platforms.
GeoVax Labs Announces Filing of IND Application for HIV Human Clinical Trial July 11, 2016
GeoVax Labs, Inc. recently announced the filing of an Investigational New Drug (IND) application with the US FDA for the...Soligenix Announces Initiation of Pivotal Phase III Clinical Trial December 15, 2015
Soligenix, Inc. recently announced that patient enrollment has been opened for its Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating...SINGLE-USE MARKET - Rise of Single-Use Technologies & Systems in Biopharmaceuticals November 19, 2015
Kevin James and Shalini S. Dewan of BCC Research believe eliminating the risk of contamination is the greatest challenge faced by manufacturers of biopharmaceuticals, and currently, this requires high-level monitoring of critical manufacturing processes. Single-use technology aids biopharmaceutical manufacturers in overcoming this challenge by reducing or eliminating the need for sterilization between batches, thereby improving operational efficiency.
12th Annual BioProcess International Conference & Exposition Is Largest in Its History November 11, 2015
- Global Forum Focused On Advancing Drug Candidates Closer to Approval Faster and...Astellas Pharma & Immunomic Therapeutics Announce $300-Million Worldwide Partnership for LAMP-vax Products October 9, 2015
Immunomic Therapeutics, Inc. and Astellas Pharma Inc. recently announced they have entered into an exclusive worldwide license agreement to the...EXECUTIVE INTERVIEW - ALTHEA: Giving Biopharmaceutical Companies the Power To Make October 5, 2015
David Enloe, Althea’s President and CEO, discusses his company’s business strategy, why companies choose Althea, trends in the CMO industry, and how the company is growing since the acquisition of Ajinomoto.
NANOSCALE PARTICLES - VAULT: A Novel Nanofrontier in Drug Delivery March 30, 2015
ABSTRACT Novel nanoscale particles (Vaults) as first described in 1986, exist in the multiples of thousands in most eukaryotic cells....Latest Frost Reports: Next-Generation Therapeutics for Infectious Diseases; Orphan Drugs Market March 31, 2014
Next-Generation Therapeutics The available antivirals for commonly occurring infections, such as respiratory syncytial virus (RSV) and influenza are characterized by...Cobra Biologics & BioCancell Announce Agreement for Promising Cancer Therapy March 7, 2014
Cobra Biologics and BioCancell recently announced an agreement to manufacture BioCancell’s BC-821 cancer drug for clinical trials. BioCancell’s Phase I...Peptineo Inks Exclusive Option for Drug Delivery Technologies December 17, 2013
Peptineo recently announced the company has inked an exclusive option for a broad set of nanotechnology patents in the area...INTRADERMAL DELIVERY - Advances in Intradermal Drug Delivery October 16, 2013
Zach Marks, MS, RPh, believes efficiency of vaccine use will be critical as the world population continues to grow and vaccine prices continue to rise, and ID administration can help reduce dose cost while potentially improving immunogenicity in traditional and hard-to-treat populations.
Roche & Inovio Enter $422.5-Million Licensing Deal September 18, 2013
Roche and Inovio Pharmaceuticals, Inc. recently announced they have entered into an exclusive worldwide license agreement to research, develop and...FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
DELIVERY DEVICES - The New Industry Paradigm for Prefilled Success March 12, 2013
Alan Shortall indicates that following a period of relative industry stability defined by peripheral innovation, a converging series of external and internal forces are set to reshape the prefilled syringe industry so that it will better serve the emerging needs of pharmaceutical companies, patients, and other stakeholders across the continuum of care.
3/6/2013 February 28, 2013
Capsugel Announces Major Acquisition Capsugel recently announced it has acquired Encap Drug Delivery. Based in Scotland, Encap's focus on liquid and...Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement February 28, 2013
Althea Technologies, Inc. and Profectus BioSciences Inc. recently announced the signing of a manufacturing supply agreement for plasmid DNA...1/23/2012 January 21, 2013
Amgen Invests $200 Million in Monoclonal Antibodies Amgen recently announced plans to build a new manufacturing facility in the Tuas...7/18/2012 July 12, 2012
Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc....
